Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

August 31, 2026

Conditions

AML, Adult

Interventions

BIOLOGICAL

iPSC-NK cells

Trial Locations (1)

RECRUITING

the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors

collaborator

Hangzhou Qihanjiyin Biotech Co.,Ltd.

UNKNOWN

lead

Zhejiang University

OTHER